NCT00044772View on ClinicalTrials.gov

Study Evaluating Venlafaxine ER in Patients With Panic Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

653

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

April 30, 2003

Study Completion Date

April 30, 2003

Conditions
Panic Disorder
Interventions
DRUG

Venlafaxine ER

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00044772 - Study Evaluating Venlafaxine ER in Patients With Panic Disorder | Biotech Hunter | Biotech Hunter